Christine Lind new CEO of Medivir AB
Ms. Lind will take up her new position on April 1, 2017, until which time she will continue in her existing role as EVP Strategic Business Development.
Ms. Lind has been Medivir’s EVP Strategic Business Development since 2015, prior to which she was VP Business Development at LifeCell Corporation in New Jersey, and has spent the majority of her career at Merrill Lynch & Co. / Bank of America Merrill Lynch in New York, where she specialised in Healthcare Investment Banking.
Ms. Lind holds a B.Sc. in Finance and Information Systems from New York University and an MBA in Finance and Management from Columbia Business School.
She succeeds Niklas Prager, who accepted the role as CEO in 2014 from a position as a Director of the Board.
Mr. Prager will continue as CEO until 1 April and will also make himself available to Ms. Lind until the Annual General Meeting on 3 May, in order to ensure an optimal and smooth transition. ■
LATEST MOVES FROM Sweden
- Kristina Franzén new CFO at Bilia
- Immunicum appoints Karin Hoogendoorn as head of CMC
- Kai Wärn proposed as new board member of AB Electrolux
- Even Frydenberg new president & CEO for Scandic
- Electrolux appoints head of major appliances Latin America
More inside POST
7,000 AT&T workers on 3-day strike Companies